Pharma Marketing Summit

Transcription

1 Amsterdam, 8th - 9th June 2011 Pharma Marketing Summit Who will I meet there? Members of the Board, Vice Presidents, Directors, Head and Senior Managers involved in the areas of: Marketing Marketing & Sales Established Brands Marketing and Business Intelligence Product Marketing and Strategic Projects Marketing and Business -to- Business Silver sponsors Barbara Jakubowska Senior Product Manager CEMEA Abbott Bas Amesz Partner Vintura Lady Angela Helene Spang Head of Products & Promotions EAME Allergan Miroslaw Lubecki Marketing & Sales Director David Setboun Sales & Marketing Director Europe AstraZeneca Bernhard Schaefer Director Global Strategic Marketing Cardiovascular Bayer Nicola Stephens Associate Director Marketing, Inflammation & Immunology Celgene Ana Cristina Fialho Sales & Marketing Director Eisai Teresa Portela Marketing Director Home Therapies Fresenius Medical Omer Diker Director Strategic Marketing & Business Development Actavis Volker Widmann Head of Established Products MSD Haluk Karabatak Caucasus and Central Asia Sales and Marketing Manager Pfizer Yves Goulnik Former Head of Global e-marketing Roche Markus Karmasin Head of Strategic Projects & Business Optimization Europe Sanofi-Aventis Maurizio Capecce General Manager

2 Amsterdam, 8th -9th June 2011 Pharma Marketing Summit Day Registration and Morning Coffee Opening Remarks from the Chairman 09:15 It s not you it s me, I just don t want a long term relationship How marketing-literate are modern pharmaceutical prescribers & consumers? What implications, if any does this have for marketing theory in the digital pharmaceutical age? Consumer Insight - How do consumers/ patients react and what their attitudes are to treatment and infomation gathering in this digital world Nicola Stephens Associate Director Marketing, Inflammation and Immunology Celgene 10:00 Pharma marketing process and its challenges in current Relationship marketing Pharma marketing in multicultural Challenges and opportunities Marketing mix between medical devices and medicinal products Practical examples and outlook in the future Teresa Portela Marketing Director Home Therapies Fresenius Medical Care 10:45 Networking Coffee Break 11:15 Marketing concepts for established products - how to leverage brand equities in late life cycle? How to identify most valuable brands - brand and market attractiveness? Marketing Direct Selling Business Development Volker Widmann Head of Established Products MSD 12:00 Interactive Discussion Panel New Tools of Pharma Marketing and Ways to Use them Future of Pharmaceutical Marketing in European Region Future of E-marketing in Pharmaceutical Industry 12:30 Lunch Nicola Stephens, AssociateDirector Marketing, Inflammation and Immunology, Celgene Volker Widmann, Head of Established Products, MSD Ana Cristina Fialho, Sales & Marketing Director, Eisai 14:00 Pharma Marketing Classics - Really the End of the Road? Market access - the only challenge to master? Promotion to physicians - an irrelevant effort? Managed networks - the future for health care systems and new partner? Providing solutions instead of managing brands - salvation or illusion? Markus Karmasin Head of Strategic Projects & Business Optimization Europe Sanofi-Aventis 14:45 Driving Brand Choice vs Marketing A Product Create loyalty and beyond to drive share gain Sell the product...without mentioning its name Establish instant acceptance and recognition in the buying process A couple of pharma/medical device examples and how we used merchandising Lady Angela Helene Spang Head of Products & Promotions EAME Allergan 15:30 Presentation by: TBA antwerpes ag 16:15 Networking Coffee Break 16:45 New Pharma Era: to be the BEST or to be the REST Challenges on Pharma during next 5 years How to face it with success old ideas - adaption approach new ideas - creativity approach new REP s - profile approach How will be Pharma in 2015? Ana Cristina Fialho Sales & Marketing Director Eisai 17:30 Don`t break up the brand Avoiding brand fragmentation Why to avoid brand fragmentation? How to prevent it? Be a brand director Bernhard Schaefer Director Global Strategic Marketing Cardiovascular Bayer 18:15 Developing new healthcare solutions & ways of interacting with stakeholders Changing healthcare market requires fundamental changes in how pharma is serving its customers New health care solutions & new ways of interacting with stakeholders are needed to create a sustainable business model for the future Marketing department plays a pivotal role in how this transition is managed Bas Amesz Partner Vintura 19:00 Cocktail Reception

3 Amsterdam, 8th -9th June 2011 Pharma Marketing Summit Day Registration and Morning Coffee Opening Remarks from the Chairman Management in intercultural context Why do the management cultures differ between countries? Cultural awareness or how to discover the differences? Should I adapt and if how far without loosing authenticity? Expat experience how to survive? How to make an international career? Miroslaw Lubecki Marketing & Sales Director Marketing in an increasing regulated Economic crisis, debt and pharma expenditure under pressure Rise of UK bribery act, mediator scandal France and impact on current promotional practices Need to invent new ways to communicate with our customers David Setboun Sales & Marketing Director Europe AstraZeneca 10:45 Networking Coffee Break 11:15 The New Era for Pharma Marketing Summary of al and pharma market changes Traditional ways of working Marketing in Emerging Market The New Marketing Model for the new Era Haluk Karabatak Caucasus and Central Asia Sales and Marketing Manager Pfizer The Future of Pharma Marketing Process Lunch Are there any new challenges of pharma marketing process? How differently companies are handling current challenges? What is the best strategy for the future? Barbara Jakubowska Senior Product Manager CEMEA Abbott 14:00 Aligning marketing mix with changing market dynamics How do we align our marketing mix strategies along with rapidly changing Some alternative ways that pharma companies choose in a branded generic The impact of these changes on Sales Forces and challenges in managing Sales Force resources Omer Diker Director Strategic Marketing & Business Development Actavis AIT market is evolving : how drive prescribers in the new dimension The case of Respiratory Allergic disease : what is the perception of stakeholders and the real severity The uniqueness of AIT commercial model in Italy: buying process and key marketing drivers Who is the customer After 100 years, AIT world is changing: how to drive the traditional behavior of prescribers to a new pharma approach Maurizio Capecce General Manager 15:30 Networking Coffee Break 16:00 Challenges of Multi-Channel Marketing Marketing mix and customer preference Integrating and measuring impact Mobile and social marketing Some emerging markets examples Other audiences and opportunities Yves Goulnik Former Head of Global e-marketing Roche 16:45 Interactive Discussion Panel European Pharmaceutical Marketing and its Current Issues Marketing: Best Practices with Regard to Privacy DTC Marketing back to Europe? Miroslaw Lubecki, Marketing & Sales Director, Maurizio Capecce, General Manager, Haluk Karabatak, Caucasus and Central Asia Sales and Marketing Manager, Pfizer Omer Diker, Director Strategic Marketing and Business Development, Actavis 17:15 Closing Remarks from the Chairman

4 Floorplan Conference Pharma Marketing Summit 8th - 9th June

5 Pharma Marketing Summit Sales Contract Conference Code AL-P-16 PLEASE FILL IN REQUIRED DETAILS IN BLOCK AND FAX or TO: Registration Details: 1. Name:... Organisation:... Address:... City: Name:... Country:... Telephone:... Fax: Name:... Company Size:... Nature of Business:... Website: Name:... VAT Reg. Number:... Payment Method Name of Card Holder:... Card Billing Address:... VISA Master Card Euro Card AMEX Diners Club Card Number Last 3 (three) digits on the back of the card Valid From [mm/yy]: / Expiry Date: / I confirm that I have read and agree to the terms and conditions of booking and allan Lloyds debiting my credit card, I the signatory is authorised to sign or behalf of contracting organisations Name:... Signature:...Date:... Conference Fee 3500 euros per delegate Two day conference Payment is required within 5 working days Conference Registration / Terms and Conditions Payment terms: After completion and return of the registration form, full payment is required within 5 days from receipt of invoice. Entry may be refuse to delegates who have not paid their invoice in full. A credit card guarantee may be requested if payment has not been received in full before the event. There is a 50% liability on all bookings once made, by fax or . A no refunds policy exists for cancellations received on or after one month before the event. Should you decide to cancel after this date the full invoice must be paid. However, if you cannot attend the conference, you may make a substitution (colleague) at least one week before first day of the event, as long as we are informed in writing by or fax. Name changes and substitutions must be from the same company. Allan Lloyds reserves the right to alter the conference content, timing, speakers or venue without notice. The event may be postponed or cancelled due to unforeseen events beyond the control of Allan Lloyds. (Force Majeure: meaning any circumstances beyond the control of Allan Lloyds, including without limitations to any Act of God, governmental restrain, fire, tempest, strike or lock-out (other than by Allan Lloyds own employees or agents), war or act of terrorism. We strongly advise all our conference clients to take out travel insurance. The conference fee includes refreshments, lunch and conference material for the event. This fee does not include travel, hotel accommodation, transfers or insurance, (which Allan Lloyds strongly recommend you obtain). We may store and process your information for administrative purposes and to better understand your needs and how we can improve our products and services. In addition, we may use that information to contact you. Please complete the registration form in full so that we can contact you and provide you with our best services.